This book is a comprehensive resource for veterinary oncologists and trainees, covering therapeutic strategies used in the treatment of veterinary patients. In the setting of a rapidly changing field like oncology, this timely text focuses on mechanisms of action and biological rationale rather than current specific clinical recommendations, allowing current and future clinicians to adapt treatment approaches as our understanding of the biology of cancer evolves. With each chapter written by experts in their field, this book provides informative figures that convey this biological understanding and rationale of therapy. It starts from the mechanisms of treatment as we currently understand them, covering radiation therapy, chemotherapy, immunotherapy, targeted therapy, and many more. Dispensing vital, detailed and practical information about the different therapeutic strategies available, this book is a vital resource for practicing veterinarians, while also providing students of veterinary oncology with a better understanding of the key differences between different treatment strategies.
Sprache
Verlagsort
Wallingford
Großbritannien
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
Maße
Höhe: 246 mm
Breite: 189 mm
Dicke: 19 mm
Gewicht
ISBN-13
978-1-78924-580-6 (9781789245806)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Chand Khanna DVM, PhD completed his veterinary training at the Western College of Veterinary Medicine in 1991. He then received specialty training in the fields of veterinary internal medicine and oncology, first at the Ontario Veterinary College, University of Guelph and then the University of Minnesota. Dr. Khanna is a board-certified diplomate of the American College of Veterinary Internal Medicine (Oncology) and was recently awarded honorary membership as a Diplomate of the American College Veterinary Pathology. Following this clinical specialization Dr. Khanna received a PhD in Pathobiology from the University of Minnesota and then completed a post-doctoral fellowship in the Pediatric Oncology Branch of the National Cancer Institute in Bethesda Maryland. Dr. Khanna has maintained a strong connection to the field of veterinary oncology and animal health. He continues to be an active clinician within his referral oncology practices, The Oncology Service, LLC, based in the greater Washington DC area. He is founder of Animal Clinical Investigation LLC, a contract research company, involved in complex medical problems seen in companion animals. Dr. Khanna is Chief Science Officer with Ethos Veterinary Health, and President of Ethos Discovery, a 501c3, its incubator of scientific innovation.
Herausgeber*in
CMO Ethos Veterinary HealthEthos Veterinary Health, USA
Beiträge von
Ethos Veterinary Health, USA
Case Western Reserve University, USA
Colorado State University, USA
Ethos Veterinary Health, USA
Pet Dx, USA
Ethos Veterinary Health, USA
Ethos Veterinary Health, USA
Ethos Veterinary Health, USA
Cummings School of Veterinary Medicine at Tufts University, USA
1: Radiation Therapy 2: High-dose Conventional Chemotherapy 3: Metronomic Chemotherapy 4: Targeting Cancer Metabolism Dependencies 5: Anti-metastatic Therapy 6: Signal Transduction Inhibitors 7: Nuclear Transport Inhibitors 8: Cancer Immunotherapy 9: Gene Editing and Gene Therapy in Oncology 10: Epigenetic Targeting in Cancer 11: Precision Medicine 12: Glucocorticoid Therapy in Oncology
